Breaking News Instant updates and real-time market news.

PLAY

Dave & Buster's

$37.55 /

-4.95 (-11.65%)

05:10
09/11/19
09/11
05:10
09/11/19
05:10

Dave & Buster's downgraded to Market Perform from Outperform at William Blair

William Blair analyst Sharon Zackfia downgraded Dave & Buster's to Market Perform from Outperform citing the "continued weakening" in the company's comp trends.

PLAY Dave & Buster's
$37.55 /

-4.95 (-11.65%)

09/11/19 Raymond James
Dave & Buster's downgraded to Market Perform from Outperform at Raymond James
09/06/19 Maxim
Dave & Buster's price target lowered to $55 from $62 at Maxim
09/05/19 Truist
Dave & Buster's price target lowered to $45 from $47 at SunTrust
07/02/19
Fly Intel: Top five analyst downgrades

TODAY'S FREE FLY STORIES

Earnings
Intra-Cellular reports Q2 EPS (96c), consensus (91c) » 07:47
08/10/20
08/10
07:47
08/10/20
07:47
ITCI

Intra-Cellular

$20.91 /

+0.32 (+1.55%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITCI Intra-Cellular
$20.91 /

+0.32 (+1.55%)

ITCI Intra-Cellular
$20.91 /

+0.32 (+1.55%)

06/04/20 Cantor Fitzgerald
Cantor reiterates $37 target on Intra-Cellular ahead of Phase 3 data
03/03/20 BTIG
Intra-Cellular price target lowered to $68 from $73 at BTIG
02/20/20
Fly Intel: Top five analyst initiations
02/19/20 Evercore ISI
Intra-Cellular initiated with an Outperform at Evercore ISI
ITCI Intra-Cellular
$20.91 /

+0.32 (+1.55%)

  • 08
    Jan
ITCI Intra-Cellular
$20.91 /

+0.32 (+1.55%)

Earnings
Biohaven Pharmaceutical reports Q2 non-GAAP EPS ($2.55), consensus ($2.61) » 07:47
08/10/20
08/10
07:47
08/10/20
07:47
BHVN

Biohaven Pharmaceutical

$67.67 /

+4.24 (+6.68%)

Reports Q2 revenue $9.7M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

07/29/20 Piper Sandler
Piper says AbbVie's atogepant 'may yet emerge as best in class'
07/29/20 Piper Sandler
Biohaven migraine competitor shows constipation signal, says Piper Sandler
07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/25/20 Mizuho
Biohaven selloff yesterday a buying opportunity, says Mizuho
BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

  • 29
    Jan
BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

BHVN Biohaven Pharmaceutical
$67.67 /

+4.24 (+6.68%)

Recommendations
Restaurant Brands price target raised to $75 from $57 at Deutsche Bank » 07:47
08/10/20
08/10
07:47
08/10/20
07:47
QSR

Restaurant Brands

$53.68 /

-1.515 (-2.74%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QSR Restaurant Brands
$53.68 /

-1.515 (-2.74%)

QSR Restaurant Brands
$53.68 /

-1.515 (-2.74%)

08/07/20 Evercore ISI
Restaurant Brands downgraded to In Line from Outperform at Evercore ISI
08/04/20 RBC Capital
Restaurant Brands price target raised to $63 from $57 at RBC Capital
06/30/20 SunTrust
Restaurant Brands price target raised to $63 from $60 at SunTrust
05/18/20 Standpoint Research
Restaurant Brands initiated with a Buy at Standpoint Research
QSR Restaurant Brands
$53.68 /

-1.515 (-2.74%)

  • 04
    Sep
QSR Restaurant Brands
$53.68 /

-1.515 (-2.74%)

QSR Restaurant Brands
$53.68 /

-1.515 (-2.74%)

Hot Stocks
Paratek Pharmaceuticals expects cash to fund operations through end of 2023 » 07:46
08/10/20
08/10
07:46
08/10/20
07:46
PRTK

Paratek Pharmaceuticals

$4.57 /

+0.075 (+1.67%)

The Company now…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

05/06/20 H.C. Wainwright
Priority Review in China accelerates revenues for Paratek, says H.C. Wainwright
04/01/20 H.C. Wainwright
Paratek BARDA funding 'kicks off' Nuzyra onshoring, says H.C. Wainwright
03/24/20 H.C. Wainwright
Paratek, Nabriva can benefit from DISARM Act passage, says H.C. Wainwright
01/08/20 WBB Securities
Paratek Pharmaceuticals initiated with a Speculative Buy at WBB Securities
PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

Earnings
Paratek Pharmaceuticals sees 2020 revenue $78M-$83M, consensus $81.16M  07:45
08/10/20
08/10
07:45
08/10/20
07:45
PRTK

Paratek Pharmaceuticals

$4.57 /

+0.075 (+1.67%)

 
ShowHide Related Items >><<
PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

05/06/20 H.C. Wainwright
Priority Review in China accelerates revenues for Paratek, says H.C. Wainwright
04/01/20 H.C. Wainwright
Paratek BARDA funding 'kicks off' Nuzyra onshoring, says H.C. Wainwright
03/24/20 H.C. Wainwright
Paratek, Nabriva can benefit from DISARM Act passage, says H.C. Wainwright
01/08/20 WBB Securities
Paratek Pharmaceuticals initiated with a Speculative Buy at WBB Securities
PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

Earnings
Paratek Pharmaceuticals reports Q2 EPS (53c), consensus (6c) » 07:45
08/10/20
08/10
07:45
08/10/20
07:45
PRTK

Paratek Pharmaceuticals

$4.57 /

+0.075 (+1.67%)

Reports Q revenue $9.3M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

05/06/20 H.C. Wainwright
Priority Review in China accelerates revenues for Paratek, says H.C. Wainwright
04/01/20 H.C. Wainwright
Paratek BARDA funding 'kicks off' Nuzyra onshoring, says H.C. Wainwright
03/24/20 H.C. Wainwright
Paratek, Nabriva can benefit from DISARM Act passage, says H.C. Wainwright
01/08/20 WBB Securities
Paratek Pharmaceuticals initiated with a Speculative Buy at WBB Securities
PRTK Paratek Pharmaceuticals
$4.57 /

+0.075 (+1.67%)

Recommendations
Norfolk Southern named Catalyst Call Buy idea at Deutsche Bank » 07:44
08/10/20
08/10
07:44
08/10/20
07:44
NSC

Norfolk Southern

$198.79 /

+2.87 (+1.46%)

, UPS

UPS

$156.84 /

+11.51 (+7.92%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NSC Norfolk Southern
$198.79 /

+2.87 (+1.46%)

UPS UPS
$156.84 /

+11.51 (+7.92%)

NSC Norfolk Southern
$198.79 /

+2.87 (+1.46%)

07/30/20 Wells Fargo
Norfolk Southern price target raised to $213 from $201 at Wells Fargo
07/30/20 Credit Suisse
Norfolk Southern price target raised to $216 from $199 at Credit Suisse
07/02/20
Fly Intel: Top five analyst upgrades
07/02/20 TD Securities
Norfolk Southern upgraded to Buy from Hold at TD Securities
UPS UPS
$156.84 /

+11.51 (+7.92%)

07:11 Today UBS
UPS price target raised to $162 from $150 at UBS
08/06/20 Oppenheimer
UPS price target raised to $153 from $106 at Oppenheimer
08/03/20 Standpoint Research
UPS downgraded to Hold from Buy at Standpoint Research
08/03/20 Stephens
UPS price target raised to $150 from $105 at Stephens
NSC Norfolk Southern
$198.79 /

+2.87 (+1.46%)

UPS UPS
$156.84 /

+11.51 (+7.92%)

UPS UPS
$156.84 /

+11.51 (+7.92%)

UPS UPS
$156.84 /

+11.51 (+7.92%)

UPS UPS
$156.84 /

+11.51 (+7.92%)

Recommendations
PennyMac Financial price target raised to $62 from $46 at Credit Suisse » 07:43
08/10/20
08/10
07:43
08/10/20
07:43
PFSI

PennyMac Financial

$51.56 /

+1.09 (+2.16%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PFSI PennyMac Financial
$51.56 /

+1.09 (+2.16%)

PFSI PennyMac Financial
$51.56 /

+1.09 (+2.16%)

08/07/20 Piper Sandler
PennyMac Financial price target raised to $70 from $62 at Piper Sandler
07/07/20 Keefe Bruyette
PennyMac Financial price target raised to $53 from $40 at Keefe Bruyette
06/15/20 Credit Suisse
PennyMac Financial price target raised to $44 from $36 at Credit Suisse
06/11/20 Barclays
PennyMac Financial price target raised to $44 from $40 at Barclays
PFSI PennyMac Financial
$51.56 /

+1.09 (+2.16%)

Earnings
Revolution Medicines reports Q2 EPS (46c), consensus (35c) » 07:43
08/10/20
08/10
07:43
08/10/20
07:43
RVMD

Revolution Medicines

$26.26 /

+0.62 (+2.42%)

Reports Q revenue $10M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RVMD Revolution Medicines
$26.26 /

+0.62 (+2.42%)

RVMD Revolution Medicines
$26.26 /

+0.62 (+2.42%)

05/21/20
Fly Intel: Top five analyst initiations
05/21/20 H.C. Wainwright
Revolution Medicines initiated with a Buy at H.C. Wainwright
03/09/20
Fly Intel: Top five analyst initiations
03/09/20 Cowen
Revolution Medicines initiated with an Outperform at Cowen
  • 09
    Jul
  • 13
    Feb
RVMD Revolution Medicines
$26.26 /

+0.62 (+2.42%)

Hot Stocks
Ranpak Holdings appoints Bill Drew as CFO » 07:41
08/10/20
08/10
07:41
08/10/20
07:41
PACK

Ranpak Holdings

$9.00 /

+0.39 (+4.53%)

Ranpak Holdings announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PACK Ranpak Holdings
$9.00 /

+0.39 (+4.53%)

09/30/19 Craig-Hallum
Ranpak Holdings initiated with a Buy at Craig-Hallum
  • 11
    Dec
Recommendations
Lyft price target lowered to $66 from $75 at Credit Suisse » 07:41
08/10/20
08/10
07:41
08/10/20
07:41
LYFT

Lyft

$30.19 /

-2.145 (-6.63%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LYFT Lyft
$30.19 /

-2.145 (-6.63%)

LYFT Lyft
$30.19 /

-2.145 (-6.63%)

08/05/20 Deutsche Bank
Lyft price target lowered to $57 from $60 at Deutsche Bank
07/22/20 Raymond James
Lyft resumed with a Market Perform at Raymond James
07/14/20
Fly Intel: Top five analyst downgrades
07/14/20 Northcoast
Lyft downgraded to Neutral from Buy at Northcoast
LYFT Lyft
$30.19 /

-2.145 (-6.63%)

LYFT Lyft
$30.19 /

-2.145 (-6.63%)

LYFT Lyft
$30.19 /

-2.145 (-6.63%)

LYFT Lyft
$30.19 /

-2.145 (-6.63%)

Earnings
Tegna reports Q2 EPS 12c, consensus 12c » 07:40
08/10/20
08/10
07:40
08/10/20
07:40
TGNA

Tegna

$11.91 /

+0.205 (+1.75%)

Reports Q2 revenue $578M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TGNA Tegna
$11.91 /

+0.205 (+1.75%)

TGNA Tegna
$11.91 /

+0.205 (+1.75%)

04/16/20 Wells Fargo
Tegna price target lowered to $11 from $18 at Wells Fargo
04/13/20 JPMorgan
Tegna price target lowered to $13 from $19 at JPMorgan
04/03/20 Barrington
Tegna price target lowered to $15 from $20 at Barrington
01/17/20 Argus
Tegna price target raised to $21 from $17 at Argus
TGNA Tegna
$11.91 /

+0.205 (+1.75%)

TGNA Tegna
$11.91 /

+0.205 (+1.75%)

TGNA Tegna
$11.91 /

+0.205 (+1.75%)

TGNA Tegna
$11.91 /

+0.205 (+1.75%)

Hot Stocks
Baudax Bio says efforts to commercialze ANJESO impacted by COVID-19 » 07:40
08/10/20
08/10
07:40
08/10/20
07:40
BXRX

Baudax Bio

$3.45 /

-0.025 (-0.72%)

The Company's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

05/15/20 JMP Securities
Baudax Bio initiated with an Outperform at JMP Securities
02/21/20 Piper Sandler
Baudax Bio price target raised to $14 from $11 at Piper Sandler
11/22/19 Janney Montgomery Scott
Baudax Bio initiated with a Buy at Janney Montgomery Scott
11/22/19 Piper Jaffray
Baudax Bio initiated with an Overweight at Piper Jaffray
BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

  • 24
    Mar
BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

Recommendations
Trade Desk price target raised to $490 from $300 at DA Davidson » 07:40
08/10/20
08/10
07:40
08/10/20
07:40
TTD

Trade Desk

$493.98 /

+13.62 (+2.84%)

DA Davidson analyst Tom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TTD Trade Desk
$493.98 /

+13.62 (+2.84%)

TTD Trade Desk
$493.98 /

+13.62 (+2.84%)

08/07/20 RBC Capital
Trade Desk price target raised to $510 from $300 at RBC Capital
08/07/20 Stephens
Trade Desk downgraded to Equal Weight from Overweight at Stephens
08/07/20 Stephens
Trade Desk downgraded to Equal Weight from Overweight at Stephens
06/22/20 Needham
Trade Desk price target raised to $475 from $370 at Needham
TTD Trade Desk
$493.98 /

+13.62 (+2.84%)

TTD Trade Desk
$493.98 /

+13.62 (+2.84%)

TTD Trade Desk
$493.98 /

+13.62 (+2.84%)

Earnings
Baudax Bio reports Q2 EPS ($1.72), consensus (65c) » 07:39
08/10/20
08/10
07:39
08/10/20
07:39
BXRX

Baudax Bio

$3.45 /

-0.025 (-0.72%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

05/15/20 JMP Securities
Baudax Bio initiated with an Outperform at JMP Securities
02/21/20 Piper Sandler
Baudax Bio price target raised to $14 from $11 at Piper Sandler
11/22/19 Janney Montgomery Scott
Baudax Bio initiated with a Buy at Janney Montgomery Scott
11/22/19 Piper Jaffray
Baudax Bio initiated with an Overweight at Piper Jaffray
BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

  • 24
    Mar
BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

BXRX Baudax Bio
$3.45 /

-0.025 (-0.72%)

Earnings
Sesen Bio reports Q2 EPS (24c), consensus (9c) » 07:39
08/10/20
08/10
07:39
08/10/20
07:39
SESN

Sesen Bio

$1.00 /

-0.01 (-0.99%)

"We are extremely…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SESN Sesen Bio
$1.00 /

-0.01 (-0.99%)

SESN Sesen Bio
$1.00 /

-0.01 (-0.99%)

SESN Sesen Bio
$1.00 /

-0.01 (-0.99%)

Recommendations
Mosaic price target raised to $17 from $14 at Goldman Sachs » 07:38
08/10/20
08/10
07:38
08/10/20
07:38
MOS

Mosaic

$17.19 /

+1.05 (+6.51%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MOS Mosaic
$17.19 /

+1.05 (+6.51%)

MOS Mosaic
$17.19 /

+1.05 (+6.51%)

07/15/20 Citi
Mosaic upgraded to Buy from Neutral at Citi
06/29/20
Fly Intel: Top five analyst upgrades
06/29/20 BofA
Mosaic upgraded to Buy from Underperform at BofA
05/11/20 BofA
Nutrien, Mosaic, Corteva, CF Industries cut to Underperform at BofA
MOS Mosaic
$17.19 /

+1.05 (+6.51%)

MOS Mosaic
$17.19 /

+1.05 (+6.51%)

MOS Mosaic
$17.19 /

+1.05 (+6.51%)

Hot Stocks
Omeros reports recovery, survival of all COVID patients in study of narsoplimab » 07:38
08/10/20
08/10
07:38
08/10/20
07:38
OMER

Omeros

$14.13 /

+0.12 (+0.86%)

Omeros said in a release,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OMER Omeros
$14.13 /

+0.12 (+0.86%)

OMER Omeros
$14.13 /

+0.12 (+0.86%)

03/04/20 Wedbush
Omeros price target raised to $22 from $18 at Wedbush
03/03/20 Cantor Fitzgerald
Omeros shares can 'significantly rerate' from here, says Cantor Fitzgerald
11/05/19 H.C. Wainwright
Omeros recent selloff appears unwarranted, says H.C. Wainwright
OMER Omeros
$14.13 /

+0.12 (+0.86%)

  • 05
    Dec
OMER Omeros
$14.13 /

+0.12 (+0.86%)

Hot Stocks
Navidea, Jubilant sign MOU worth $19M for Rheumatoid Arthritis Diagnostic ELDA » 07:38
08/10/20
08/10
07:38
08/10/20
07:38
NAVB

Navidea

$4.71 /

-0.09 (-1.88%)

Navidea announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NAVB Navidea
$4.71 /

-0.09 (-1.88%)

NAVB Navidea
$4.71 /

-0.09 (-1.88%)

05/22/20 H.C. Wainwright
Navidea price target raised to $6 from $4 at H.C. Wainwright
11/22/19 H.C. Wainwright
Navidea initiated with a Buy at H.C. Wainwright
NAVB Navidea
$4.71 /

-0.09 (-1.88%)

Hot Stocks
Axsome Therapeutics expects cash to fund operations for at least two years » 07:38
08/10/20
08/10
07:38
08/10/20
07:38
AXSM

Axsome Therapeutics

$78.20 /

+0.14 (+0.18%)

Axsome believes that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
04/28/20 SunTrust
Axsome Therapeutics price target raised to $200 from $145 at SunTrust
04/28/20 Cantor Fitzgerald
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

  • 19
    Dec
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

Recommendations
Mr. Cooper price target raised to $24 from $16 at Credit Suisse » 07:38
08/10/20
08/10
07:38
08/10/20
07:38
COOP

Mr. Cooper

$17.98 /

-0.26 (-1.43%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COOP Mr. Cooper
$17.98 /

-0.26 (-1.43%)

COOP Mr. Cooper
$17.98 /

-0.26 (-1.43%)

08/03/20 Piper Sandler
Mr. Cooper price target raised to $25 from $15 at Piper Sandler
07/31/20 Barclays
Barclays upgrades Mr. Cooper to Overweight with refis in 'earlier innings'
07/31/20 Barclays
Mr. Cooper upgraded to Overweight from Equal Weight at Barclays
07/07/20 KeyBanc
Mr. Cooper price target raised to $14 from $12 at KeyBanc
COOP Mr. Cooper
$17.98 /

-0.26 (-1.43%)

COOP Mr. Cooper
$17.98 /

-0.26 (-1.43%)

Hot Stocks
Axsome Therapeutics announces anticipated milestones » 07:37
08/10/20
08/10
07:37
08/10/20
07:37
AXSM

Axsome Therapeutics

$78.20 /

+0.14 (+0.18%)

Anticipated Milestones:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
04/28/20 SunTrust
Axsome Therapeutics price target raised to $200 from $145 at SunTrust
04/28/20 Cantor Fitzgerald
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

  • 19
    Dec
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

Recommendations
AmerisourceBergen price target raised to $118 from $111 at Credit Suisse » 07:36
08/10/20
08/10
07:36
08/10/20
07:36
ABC

AmerisourceBergen

$102.10 /

+0.5 (+0.49%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

06/15/20 Morgan Stanley
Morgan Stanley upgrades AmerisourceBergen on opioid settlement potential
06/15/20 Morgan Stanley
AmerisourceBergen upgraded to Overweight from Equal Weight at Morgan Stanley
05/22/20 Wolfe Research
McKesson upgraded to Outperform from Peer Perform at Wolfe Research
05/18/20 Argus
Argus sees long term growth opportunities for AmerisourceBergen
ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

Earnings
Axsome Therapeutics reports Q2 EPS (49c), consensus (62c) » 07:36
08/10/20
08/10
07:36
08/10/20
07:36
AXSM

Axsome Therapeutics

$78.20 /

+0.14 (+0.18%)

"Axsome is committed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
04/28/20 SunTrust
Axsome Therapeutics price target raised to $200 from $145 at SunTrust
04/28/20 Cantor Fitzgerald
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

  • 19
    Dec
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

Recommendations
Etsy price target raised to $160 from $90 at DA Davidson » 07:35
08/10/20
08/10
07:35
08/10/20
07:35
ETSY

Etsy

$135.21 /

+4.55 (+3.48%)

DA Davidson analyst Tom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ETSY Etsy
$135.21 /

+4.55 (+3.48%)

ETSY Etsy
$135.21 /

+4.55 (+3.48%)

08/06/20 KeyBanc
Etsy price target raised to $150 from $115 at KeyBanc
08/06/20
Fly Intel: Top five analyst upgrades
08/06/20 Morgan Stanley
Morgan Stanley stays Underweight on Etsy, wonder is this 'as good as it gets?'
08/06/20 Truist
Etsy price target raised to $162 from $112 at Truist
ETSY Etsy
$135.21 /

+4.55 (+3.48%)

ETSY Etsy
$135.21 /

+4.55 (+3.48%)

ETSY Etsy
$135.21 /

+4.55 (+3.48%)

ETSY Etsy
$135.21 /

+4.55 (+3.48%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.